Related Articles
Effective elimination of chronic lymphocytic leukemia cells in the stromal microenvironment by a novel drug combination strategy using redox-mediated mechanisms
Challenges associated with the use of Bruton's tyrosine kinase inhibitors: A life‑saving therapy for chronic lymphocytic leukemia (Review)
Management of patients with chronic lymphocytic leukemia during the SARS‑CoV‑2 pandemic (Review)
Histone deacetylase inhibitors: A novel target of anticancer therapy (Review)
Ibrutinib in CLL/SLL: From bench to bedside (Review)